GlaxoSmithKline and Merck KGaA have struck an immunotherapy deal worth up to $4 billion
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
Merck KGaA wins GSK for immunotherapy deal worth up to $4.2 billionGlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agree...
और पढो »
Stocks making the biggest moves premarket: Viacom, Centene, Merck, Alphabet & moreSome of the names on the move ahead of the open.
और पढो »
Merck named the best pharma stock by Bank of AmericaBank of America named Merck its top pick among the many U.S. pharmaceutical stocks thanks to the growing success of its key cancer drug.
और पढो »
Stocks making the biggest moves premarket: Amazon, Merck, Cigna, Honeywell & moreSome of the names on the move ahead of the open.
और पढो »
Stocks making the biggest moves midday: Amazon, Merck, Exxon Mobil & moreThese are the stocks posting the largest moves midday Friday.
और पढो »
Merck KGaA wins GSK for immunotherapy deal worth up to $4.2 billionGlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agree...
और पढो »